Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cholesterol: Significance and Regulation

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

JCL roundtable: Lipid treatment targets.

Journal of clinical lipidology·2019

Same journal

The consensus model for regulation of APRNs: Implications for nurse practitioners.

Journal of the American Academy of Nurse Practitioners·2015

Same journal

Effectiveness of nurse practitioner coordinated team group visits for type 2 diabetes in medically underserved Appalachia.

Journal of the American Academy of Nurse Practitioners·2012

Same journal

Prevalence of postpartum depression among Hispanic immigrant women.

Journal of the American Academy of Nurse Practitioners·2012

Same journal

A description of barriers and facilitators to childhood vaccinations in the military health system.

Journal of the American Academy of Nurse Practitioners·2012

Same journal

Evidence-based practice for the busy nurse practitioner: part three: critical appraisal process.

Journal of the American Academy of Nurse Practitioners·2012

Same journal

Obstructive sleep apnea hypopnea syndrome and metabolic syndrome: a synergistic cardiovascular risk factor.

Journal of the American Academy of Nurse Practitioners·2012

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 7, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

Heterozygous familial hypercholesterolemia case study.

Debra A Friedrich¹

¹College of Nursing, University of South Florida, Tampa, Florida, USA. Dfried1960@aol.com

Journal of the American Academy of Nurse Practitioners

|November 3, 2010

Summary

This summary is machine-generated.

Heterozygous familial hypercholesterolemia (HeFH) is a common genetic disorder leading to early atherosclerosis. Early screening, detection, and treatment are crucial for reducing mortality and morbidity from this condition.

More Related Videos

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

A Murine Model of Hyperlipidemia-Induced Heart Failure with Preserved Ejection Fraction

A Murine Model of Hyperlipidemia-Induced Heart Failure with Preserved Ejection Fraction

Published on: March 29, 2024

Related Experiment Videos

Last Updated: Jun 7, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

A Murine Model of Hyperlipidemia-Induced Heart Failure with Preserved Ejection Fraction

A Murine Model of Hyperlipidemia-Induced Heart Failure with Preserved Ejection Fraction

Published on: March 29, 2024

Area of Science:

Cardiology
Genetics
Public Health

Background:

Familial hypercholesterolemia (FH) is an inherited disorder characterized by high cholesterol levels.
Heterozygous FH (HeFH) affects approximately 1 in 250 individuals, increasing the risk of premature cardiovascular disease.
Primary care settings are crucial for identifying and managing HeFH.

Observation:

A case study of a young French Canadian male with HeFH in a primary care setting.
Evaluation included patient history, physical examination, and laboratory results.
Literature review encompassed epidemiology, pathophysiology, etiology, and treatment guidelines.

Findings:

HeFH is a significant genetic disorder causing premature atherosclerosis.
Early identification and intervention are vital for managing HeFH.
Effective management strategies can reduce associated morbidity and mortality.

Implications:

Clinicians must understand hypercholesterolemia and the atherogenic process.
Physical exams and laboratory findings are key for early identification of HeFH.
Prompt intervention in children and adults at risk can prevent early cardiovascular disease.